Matthew Klinge1, Tami Coppler2, Jane M Liebschutz3, Mohannad Dugum1, Ajay Wassan4, Andrea DiMartini5,6, Shari Rogal1,6,7. 1. Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh. 2. Division of Pharmacy, VA Pittsburgh Healthcare System. 3. Division of General Internal Medicine, University of Pittsburgh. 4. Department of Anesthesiology, University of Pittsburgh. 5. Department of Psychiatry, University of Pittsburgh. 6. Department of Surgery, University of Pittsburgh. 7. Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System.
Abstract
PURPOSE OF REVIEW: The treatment of pain in patients with cirrhosis is complicated by unpredictable hepatic drug metabolism and a higher risk of adverse drug reactions. We aimed to conduct a scoping review regarding pain management in cirrhosis. RECENT FINDINGS: Despite the high prevalence of pain in patients with cirrhosis, there is little literature to guide the management of pain in this population. Complex pain syndromes and disease-specific pain etiologies exist are common in patients with cirrhosis. There are numerous contraindications and limitations when considering pharmacotherapy for analgesia in cirrhosis, specifically with non-steroidal anti-inflammatory drugs (NSAIDS) and opioid medications. Non-pharmacologic therapies for pain have not been specifically assessed in this population. SUMMARY: As with other populations, a multi-dimensional treatment approach to pain with a focus on physical, behavioral, procedural and pharmacologic treatment is recommended when caring for patients with cirrhosis and pain. However, more research is needed to evaluate opioid-sparing and non-pharmacologic analgesia in this population.
PURPOSE OF REVIEW: The treatment of pain in patients with cirrhosis is complicated by unpredictable hepatic drug metabolism and a higher risk of adverse drug reactions. We aimed to conduct a scoping review regarding pain management in cirrhosis. RECENT FINDINGS: Despite the high prevalence of pain in patients with cirrhosis, there is little literature to guide the management of pain in this population. Complex pain syndromes and disease-specific pain etiologies exist are common in patients with cirrhosis. There are numerous contraindications and limitations when considering pharmacotherapy for analgesia in cirrhosis, specifically with non-steroidal anti-inflammatory drugs (NSAIDS) and opioid medications. Non-pharmacologic therapies for pain have not been specifically assessed in this population. SUMMARY: As with other populations, a multi-dimensional treatment approach to pain with a focus on physical, behavioral, procedural and pharmacologic treatment is recommended when caring for patients with cirrhosis and pain. However, more research is needed to evaluate opioid-sparing and non-pharmacologic analgesia in this population.
Authors: Okechukwu Mgbemena; Andrew O Westfall; Christine S Ritchie; Jennifer Hicks; James L Raper; Edgar Turner Overton; Wynne E Norton; Jessica S Merlin Journal: AIDS Care Date: 2014-07-25
Authors: Shari S Rogal; Klaus Bielefeldt; Ajay D Wasan; Eva Szigethy; Francis Lotrich; Andrea F DiMartini Journal: Dig Dis Sci Date: 2014-11-30 Impact factor: 3.199
Authors: C Acharya; N S Betrapally; P M Gillevet; R K Sterling; H Akbarali; M B White; D Ganapathy; A Fagan; M Sikaroodi; J S Bajaj Journal: Aliment Pharmacol Ther Date: 2016-11-20 Impact factor: 8.171
Authors: Robert H Dworkin; Alec B O'Connor; Joseph Audette; Ralf Baron; Geoffrey K Gourlay; Maija L Haanpää; Joel L Kent; Elliot J Krane; Alyssa A Lebel; Robert M Levy; Sean C Mackey; John Mayer; Christine Miaskowski; Srinivasa N Raja; Andrew S C Rice; Kenneth E Schmader; Brett Stacey; Steven Stanos; Rolf-Detlef Treede; Dennis C Turk; Gary A Walco; Christopher D Wells Journal: Mayo Clin Proc Date: 2010-03 Impact factor: 7.616
Authors: Aldo J Montano-Loza; Judith Meza-Junco; Carla M M Prado; Jessica R Lieffers; Vickie E Baracos; Vincent G Bain; Michael B Sawyer Journal: Clin Gastroenterol Hepatol Date: 2011-09-03 Impact factor: 11.382
Authors: Erin E Krebs; Karl A Lorenz; Matthew J Bair; Teresa M Damush; Jingwei Wu; Jason M Sutherland; Steven M Asch; Kurt Kroenke Journal: J Gen Intern Med Date: 2009-05-06 Impact factor: 5.128
Authors: Shari S Rogal; Matthew J Chinman; William DeMonte; Sandra Gibson; Stephanie Hoyt-Trapp; Gloria J Klima; Naudia L Jonassaint; Jane M Liebschutz; Kevin L Kraemer; Jessica Merlin Journal: Dig Dis Sci Date: 2022-02-11 Impact factor: 3.487
Authors: Dennis Hundersmarck; Olivier Q Groot; Henk J Schuijt; Falco Hietbrink; Luke P H Leenen; Marilyn Heng Journal: Clin Orthop Relat Res Date: 2021-12-31 Impact factor: 4.755
Authors: Olufunso M Agbalajobi; Theresa Gmelin; Andrew M Moon; Wheytnie Alexandre; Grace Zhang; Walid F Gellad; Naudia Jonassaint; Shari S Rogal Journal: PLoS One Date: 2021-12-17 Impact factor: 3.240
Authors: Franklin Gorospe; Laura Istanboulian; Martine Puts; David Wong; Elizabeth Lee; Craig Dale Journal: BMJ Open Date: 2019-11-11 Impact factor: 2.692